Browsing by Author ZHU FENG

Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
2009Comparative analysis of machine learning methods in ligand-based virtual screening of large compound librariesMa, X.H.; Jia, J.; Zhu, F. ; Xue, Y.; Li, Z.R.; Chen, Y.Z.
2009Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: A cohort studyZhu, F. ; Yeoh, K.G. ; Loh, M. ; Lee, S. ; Koh, K.X.; Lai, K.W. ; Salto-Tellez, M. ; Soong, R. ; Hill, J.; Iacopetta, B.
2009Mechanisms of drug combinations: Interaction and network perspectivesJia, J.; Zhu, F. ; Ma, X.; Chen, Y.Z. ; Cao, Z.W.; Li, Y.X.
2009Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to raceLoh, M.; Koh, K.X.; Soong, R. ; Yeo, B.H.; Song, C.M.; Chia, K.S. ; Zhu, F. ; Yeoh, K.G. ; Hill, J.; Iacopetta, B. 
2009Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to raceLoh, M.; Koh, K.X.; Soong, R. ; Yeo, B.H.; Song, C.M.; Chia, K.S. ; Zhu, F. ; Yeoh, K.G. ; Hill, J.; Iacopetta, B.
Sep-2011The Asia-Pacific Colorectal Screening score: A validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjectsYeoh, K.-G. ; Ho, K.-Y. ; Chiu, H.-M.; Zhu, F. ; Ching, J.Y.L.; Wu, D.-C.; Matsuda, T.; Byeon, J.-S.; Lee, S.-K.; Goh, K.-L.; Sollano, J.; Rerknimitr, R.; Leong, R.; Tsoi, K.; Lin, J.-T.; Sung, J.J.Y.
2009Update of TTD: Therapeutic Target DatabaseZhu, F. ; Han, B.; Kumar, P. ; Liu, X.; Ma, X.; Wei, X.; Huang, L.; Guo, Y.; Han, L.; Zheng, C. ; Chen, Y.
2012Validation of the functional assessment of cancer therapy-gastric module for the Chinese populationZhou H.J. ; So J.B. ; Yong W.P. ; Luo N. ; Zhu F. ; Naidoo N.; Li S.C.; Yeoh K.G. 
2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targetsZhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Chen, Y. ; Tammi, M.T. ; Yang, S.; Wei, Y.
2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.Zhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
2012Whole-genome reconstruction and mutational signatures in gastric cancerNagarajan N. ; Bertrand D.; Hillmer A.M.; Zang Z.J.; Yao F.; Jacques P.; Teo A.S.; Cutcutache I. ; Zhang Z.; Lee W.H.; Sia Y.Y.; Gao S.; Ariyaratne P.N.; Ho A.; Woo X.Y.; Veeravali L.; Ong C.K.; Deng N.; Desai K.V.; Khor C.C.; Hibberd M.L.; Shahab A.; Rao J.; Wu M.; Teh M. ; Zhu F. ; Chin S.Y.; Pang B. ; So J.B. ; Bourque G.; Soong R.; Sung W.-K. ; Tean Teh B.; Rozen S. ; Ruan X.; Yeoh K.G. ; Tan P.B. ; Ruan Y.